Society guidelines have left clinicians with some questionable recommendations Glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1 RAs), such as semaglutide and tirzepatide, are becoming increasingly prescribed to treat diabetes mellitus and obesity
What about the MIC blend
Safety Considerations and Provider Guidance Both peptides generally show favorable safety profiles in clinical contexts, but individual risk factors and medical histories influence suitability
This step is especially important when peptides will be combined or drawn frequently
In general, BMT was safe and well tolerated
These injections are the most common: trigger point injections joint injections, including those for the sacroiliac joint, hip, knee, and shoulder facet joint injections epidural steroids There are a few considerations to keep in mind for each kind of injection